Chemical Compound Review:
ENOXIMONE 4-methyl-5-(4- methylsulfanylphenyl) carbony...
Synonyms:
Enoximona, Perfane, Enoximonum, Fenoximone, Perfan, ...
- Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement. Shah, P.K., Amin, D.K., Hulse, S., Shellock, F., Swan, H.J. Circulation (1985)
- Reduction in pulmonary hypertension and in airway resistances by enoximone (MDL 17,043) in decompensated COPD. Leeman, M., Lejeune, P., Melot, C., Naeije, R. Chest (1987)
- Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043. Uretsky, B.F., Valdes, A.M., Reddy, P.S. Circulation (1986)
- Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Endoh, M., Yanagisawa, T., Taira, N., Blinks, J.R. Circulation (1986)
- Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure. Installé, E., Gonzalez, M., Jacquemart, J.L., Collard, P., Roulette, F., Pourbaix, S., Tremouroux, J. Am. J. Cardiol. (1987)
- Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy. Likoff, M.J., Ulrich, S., Hakki, A., Iskandrian, A.S. Am. J. Cardiol. (1986)
- Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure. Amin, D.K., Shah, P.K., Hulse, S., Shellock, F. Am. Heart J. (1985)
- Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure. Kereiakes, D.J., Viquerat, C., Lanzer, P., Botvinick, E.H., Spangenberg, R., Buckingham, M., Parmley, W.W., Chatterjee, K. Am. Heart J. (1984)
- Biochemical studies on the mechanism of cardiotonic activity of MDL 17,043. Kariya, T., Wille, L.J., Dage, R.C. J. Cardiovasc. Pharmacol. (1982)
- Enoximon-echocardiography. A new diagnostic approach for the detection of viable myocardium comparison to dobutamin-echocardiography. Baumgart, D., Buck, T., Leischik, R., Oelert, H., Farahati, J., Reiners, C., Erbel, R. Herz. (1994)
- Simultaneous analysis of a new cardiotonic agent, MDL 17,043, and its major sulfoxide metabolite in plasma by high-performance liquid chromatography. Chan, K.Y., Ohlweiler, D.F., Lang, J.F., Okerholm, R.A. J. Chromatogr. (1984)
- Effects of enoximone and isobutylmethylxanthine on contractile tension and cyclic nucleotide levels in isolated blood-perfused dog papillary muscle. Hsieh, C.P., Kariya, T., Dage, R.C., Ruberg, S.J. J. Cardiovasc. Pharmacol. (1987)
- Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy. Weber, K.T., Janicki, J.S., Jain, M.C. Am. J. Cardiol. (1986)
- Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure. Uretsky, B.F., Verbalis, J.G., Generalovich, T., Valdes, A., Reddy, P.S. Am. J. Physiol. (1985)
- Improved patient selection for TAH implantation. Loisance, D., Dubois Rande, J.L., Deleuze, P., Benvenuti, C., Dervanian, P., Brunet, S., Hillion, M.L., Castaigne, A., Cachera, J.P. ASAIO transactions / American Society for Artificial Internal Organs. (1989)
- Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts. Bethke, T., Eschenhagen, T., Klimkiewicz, A., Kohl, C., von der Leyen, H., Mehl, H., Mende, U., Meyer, W., Neumann, J., Rosswag, S. Arzneimittel-Forschung. (1992)
- Quantitative determination of cardiotonic agent MDL 17,043 in plasma by reversed-phase high-performance liquid chromatography. Chan, K.Y., Lang, J.F., Okerholm, R.A. J. Chromatogr. (1983)
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance. Crawford, M.H., Richards, K.L., Sodums, M.T., Kennedy, G.T. Am. J. Cardiol. (1984)
- Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one). Dage, R.C., Roebel, L.E., Hsieh, C.P., Weiner, D.L., Woodward, J.K. J. Cardiovasc. Pharmacol. (1982)